National Cancer Registry

National Cancer Registry (NCR)

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G04BE03	SILDENAFIL ARROW LAB	G	Sildenafil - 100mg	100mg	Tablet, film coated	3,192,970 L.L
A07EC02	SALCROZINE	G	Mesalazine - 500mg	500mg	Tablet, gastroresistant	2,013,076 L.L
G04BE03	SILDENAFIL STRAGEN	G	Sildenafil - 20mg	20mg	Tablet, coated	38,048,630 L.L
A07EC02	SALCROZINE	G	Mesalazine - 1g	1g	Tablet, gastroresistant	4,073,187 L.L
S03AA30	SULFACHLOR	G	Sulfacetamide sodium - 110mg/ml, Chloramphenicol - 5mg/ml		Drops solution	202,216 L.L
A07EC02	SALCROZINE	G	Mesalazine - 500mg	500mg	Suppository	576,508 L.L
A07EC02	SALCROZINE	G	Mesalazine - 1000mg	1000mg	Suppository	2,306,034 L.L
N01AH03	SUFENTANIL RENAUDIN	G	Sufentanil (citrate) - 250mcg/5ml	250mcg/5ml	Injectable solution	3,524,899 L.L
N01AH03	SUFENTANIL RENAUDIN	G	Sufentanil (citrate) - 5mcg/ml	10mcg/2ml	Injectable solution	755,239 L.L
P01AB01	SOLUFLEX METRONIDAZOLE	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	162,541 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
P01AB07	SNAD	G	Secnidazole - 500mg	500mg	Tablet	774,053 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
J01MA02	SUPERFLOX	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film-scored	458,250 L.L
N03AX09	SEIZET 25	G	Lamotrigine - 25mg	25mg	Tablet, dispersible/ chewable	573,821 L.L
P01AB07	SECNOL	G	Secnidazole anhydre - 2g	2g	Granules	842,589 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
P01AB07	SECNOL	G	Secnidazole - 2g	2g	Granules	842,589 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	205,703 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	221,792 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 500mg, Cinchocaine HCl - 500mg		Cream	290,270 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	185,018 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 5mg, Cinchocaine HCl - 5mg, Framycetin sulfate - 10mg, Esculoside - 10mg		Suppository	237,860 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 5mg, Lidocaine - 60mg, Zinc oxide - 400mg, Aluminium Subacetate - 50mg		Suppository	501,253 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 0.275g/100g, Lidocaine - 5g/100g, Zinc oxide - 18g/100g, Aluminium Subacetate - 3.5g/100g		Ointment	330,585 L.L
C10AA07	SINLIP	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	563,070 L.L
N05BA25	SEDOXIL	G	Mexazolam - 1mg	1mg	Tablet	1,705,336 L.L

...